Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Quantum Theory | 1 | 2022 | 28 | 0.840 |
Why?
|
| Silicon | 1 | 2022 | 18 | 0.840 |
Why?
|
| Rectal Neoplasms | 3 | 1994 | 116 | 0.290 |
Why?
|
| Receptors, Progesterone | 6 | 1988 | 167 | 0.290 |
Why?
|
| Colonic Neoplasms | 4 | 1993 | 556 | 0.230 |
Why?
|
| Receptors, Estrogen | 5 | 1988 | 384 | 0.230 |
Why?
|
| Biopsy, Needle | 3 | 1993 | 235 | 0.220 |
Why?
|
| Breast Neoplasms | 10 | 1995 | 2886 | 0.210 |
Why?
|
| Electrons | 1 | 2022 | 49 | 0.210 |
Why?
|
| Megestrol | 3 | 1988 | 4 | 0.170 |
Why?
|
| Carcinoma | 3 | 1991 | 436 | 0.160 |
Why?
|
| Liver | 2 | 1995 | 1229 | 0.150 |
Why?
|
| Cholecystectomy, Laparoscopic | 2 | 1993 | 50 | 0.130 |
Why?
|
| Liver Regeneration | 1 | 1995 | 32 | 0.130 |
Why?
|
| Radiation Tolerance | 1 | 1995 | 168 | 0.130 |
Why?
|
| Mastectomy | 2 | 1995 | 236 | 0.110 |
Why?
|
| Neoplasm Metastasis | 5 | 1995 | 1056 | 0.110 |
Why?
|
| Breast | 2 | 1995 | 286 | 0.110 |
Why?
|
| Thyroid Nodule | 1 | 1993 | 51 | 0.110 |
Why?
|
| Thoracotomy | 1 | 1993 | 58 | 0.110 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 1992 | 15 | 0.110 |
Why?
|
| Molybdenum | 3 | 1980 | 12 | 0.110 |
Why?
|
| Cytosol | 3 | 1980 | 189 | 0.100 |
Why?
|
| Ileum | 1 | 1992 | 159 | 0.100 |
Why?
|
| Breast Diseases | 2 | 1991 | 97 | 0.100 |
Why?
|
| Parathyroid Glands | 2 | 1988 | 74 | 0.090 |
Why?
|
| Chitin | 1 | 1990 | 10 | 0.090 |
Why?
|
| Rats, Inbred Strains | 4 | 1992 | 312 | 0.090 |
Why?
|
| Wound Healing | 1 | 1992 | 344 | 0.090 |
Why?
|
| Hemostatics | 1 | 1990 | 56 | 0.090 |
Why?
|
| Hyperthermia, Induced | 1 | 1990 | 72 | 0.090 |
Why?
|
| Nervous System Neoplasms | 1 | 1988 | 11 | 0.090 |
Why?
|
| Choriocarcinoma | 1 | 1988 | 7 | 0.080 |
Why?
|
| Thyroid Neoplasms | 2 | 1993 | 408 | 0.080 |
Why?
|
| Endocrine System Diseases | 1 | 1988 | 23 | 0.080 |
Why?
|
| Thyroid Diseases | 1 | 1989 | 104 | 0.080 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1990 | 124 | 0.080 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 1988 | 43 | 0.080 |
Why?
|
| Rats | 6 | 1995 | 3990 | 0.080 |
Why?
|
| Laser Therapy | 1 | 1990 | 142 | 0.080 |
Why?
|
| Gallium Radioisotopes | 1 | 1988 | 32 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 1988 | 2436 | 0.080 |
Why?
|
| Aged | 12 | 1995 | 18398 | 0.080 |
Why?
|
| Middle Aged | 15 | 1995 | 25013 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 1 | 1990 | 503 | 0.080 |
Why?
|
| Cyclosporins | 1 | 1987 | 59 | 0.070 |
Why?
|
| Aged, 80 and over | 7 | 1995 | 6501 | 0.070 |
Why?
|
| Retrospective Studies | 7 | 1995 | 8464 | 0.070 |
Why?
|
| Laparoscopy | 1 | 1993 | 754 | 0.070 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 1987 | 225 | 0.060 |
Why?
|
| Female | 16 | 1995 | 44489 | 0.060 |
Why?
|
| Adult | 11 | 1995 | 25627 | 0.060 |
Why?
|
| Melanoma | 1 | 1988 | 454 | 0.060 |
Why?
|
| Internship and Residency | 1 | 1993 | 1002 | 0.060 |
Why?
|
| Random Allocation | 2 | 1995 | 332 | 0.060 |
Why?
|
| Megestrol Acetate | 3 | 1988 | 10 | 0.060 |
Why?
|
| Graft Survival | 1 | 1987 | 884 | 0.060 |
Why?
|
| Humans | 23 | 1995 | 86526 | 0.060 |
Why?
|
| Neoplasm Staging | 4 | 1994 | 1937 | 0.050 |
Why?
|
| Male | 12 | 1995 | 40944 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 1993 | 2261 | 0.050 |
Why?
|
| Regression Analysis | 2 | 1994 | 596 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 2 | 1991 | 274 | 0.040 |
Why?
|
| Prognosis | 3 | 1993 | 3673 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 1993 | 1564 | 0.040 |
Why?
|
| Tamoxifen | 2 | 1988 | 168 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 1994 | 1671 | 0.040 |
Why?
|
| Mammography | 2 | 1991 | 461 | 0.040 |
Why?
|
| Cholangiography | 2 | 1993 | 41 | 0.040 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1995 | 27 | 0.030 |
Why?
|
| Mastectomy, Modified Radical | 1 | 1995 | 6 | 0.030 |
Why?
|
| Mastectomy, Radical | 1 | 1995 | 10 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 1995 | 73 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 1995 | 73 | 0.030 |
Why?
|
| Mastectomy, Subcutaneous | 1 | 1995 | 8 | 0.030 |
Why?
|
| Bilirubin | 1 | 1995 | 125 | 0.030 |
Why?
|
| Animals | 6 | 1995 | 26567 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 1990 | 1753 | 0.030 |
Why?
|
| Carcinoma, Lobular | 1 | 1995 | 80 | 0.030 |
Why?
|
| Hepatectomy | 1 | 1995 | 166 | 0.030 |
Why?
|
| Prospective Studies | 3 | 1993 | 4208 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 1993 | 63 | 0.030 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 1995 | 156 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 1993 | 216 | 0.030 |
Why?
|
| Cholecystectomy | 1 | 1993 | 18 | 0.030 |
Why?
|
| Anastomosis, Surgical | 2 | 1992 | 267 | 0.030 |
Why?
|
| Lymphatic Metastasis | 2 | 1994 | 481 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 1993 | 90 | 0.030 |
Why?
|
| Pilot Projects | 1 | 1995 | 839 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 1219 | 0.030 |
Why?
|
| Hydroxyproline | 1 | 1992 | 11 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 1994 | 552 | 0.030 |
Why?
|
| Tensile Strength | 1 | 1992 | 78 | 0.030 |
Why?
|
| Risk Factors | 2 | 1994 | 5413 | 0.030 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 1991 | 111 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 1994 | 1988 | 0.030 |
Why?
|
| Biopsy | 1 | 1995 | 1161 | 0.030 |
Why?
|
| Palpation | 1 | 1991 | 18 | 0.020 |
Why?
|
| Fibroma | 1 | 1991 | 32 | 0.020 |
Why?
|
| Stereotaxic Techniques | 1 | 1991 | 69 | 0.020 |
Why?
|
| Carcinoma in Situ | 1 | 1991 | 53 | 0.020 |
Why?
|
| Killer Cells, Lymphokine-Activated | 1 | 1989 | 27 | 0.020 |
Why?
|
| Chitosan | 1 | 1990 | 18 | 0.020 |
Why?
|
| Incidence | 1 | 1994 | 1576 | 0.020 |
Why?
|
| Survival Rate | 1 | 1993 | 1860 | 0.020 |
Why?
|
| Xeromammography | 1 | 1988 | 1 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1989 | 196 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 1995 | 2232 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1988 | 503 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 1988 | 61 | 0.020 |
Why?
|
| HLA-D Antigens | 1 | 1988 | 20 | 0.020 |
Why?
|
| Menopause | 1 | 1988 | 71 | 0.020 |
Why?
|
| HLA-DQ Antigens | 1 | 1988 | 52 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1988 | 220 | 0.020 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1988 | 126 | 0.020 |
Why?
|
| Clinical Competence | 1 | 1993 | 751 | 0.020 |
Why?
|
| Remission Induction | 1 | 1988 | 722 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1987 | 158 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 1993 | 2205 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 1988 | 322 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 1991 | 1800 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 1988 | 424 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 1987 | 996 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 1988 | 544 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 1990 | 1458 | 0.010 |
Why?
|
| Algorithms | 1 | 1991 | 1830 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 1987 | 705 | 0.010 |
Why?
|
| Charcoal | 1 | 1980 | 13 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1980 | 112 | 0.010 |
Why?
|
| Dextrans | 1 | 1980 | 77 | 0.010 |
Why?
|
| Tritium | 1 | 1980 | 133 | 0.010 |
Why?
|
| Promegestone | 1 | 1980 | 4 | 0.010 |
Why?
|
| Progesterone | 1 | 1980 | 110 | 0.010 |
Why?
|
| Uterus | 1 | 1980 | 215 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1980 | 989 | 0.010 |
Why?
|
| Melphalan | 1 | 1977 | 97 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1988 | 3350 | 0.010 |
Why?
|
| Age Factors | 1 | 1980 | 1849 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1977 | 556 | 0.010 |
Why?
|
| Adolescent | 1 | 1988 | 8976 | 0.010 |
Why?
|
| Puerto Rico | 1 | 1993 | 31 | 0.010 |
Why?
|
| Laparotomy | 1 | 1993 | 59 | 0.010 |
Why?
|
| Bile Ducts | 1 | 1993 | 59 | 0.010 |
Why?
|
| Morbidity | 1 | 1993 | 148 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 1993 | 82 | 0.010 |
Why?
|
| Data Collection | 1 | 1993 | 372 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 1993 | 185 | 0.010 |
Why?
|
| Eicosanoids | 1 | 1989 | 16 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1989 | 213 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1988 | 44 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1988 | 316 | 0.000 |
Why?
|
| Inguinal Canal | 1 | 1987 | 5 | 0.000 |
Why?
|
| Rats, Inbred WF | 1 | 1987 | 8 | 0.000 |
Why?
|
| Femoral Vein | 1 | 1987 | 35 | 0.000 |
Why?
|
| Rats, Inbred Lew | 1 | 1987 | 186 | 0.000 |
Why?
|
| Femoral Artery | 1 | 1987 | 81 | 0.000 |
Why?
|
| ROC Curve | 1 | 1988 | 752 | 0.000 |
Why?
|
| Aorta | 1 | 1987 | 280 | 0.000 |
Why?
|
| Pulmonary Artery | 1 | 1987 | 305 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1989 | 2818 | 0.000 |
Why?
|
| Immunotherapy | 1 | 1989 | 629 | 0.000 |
Why?
|
| United States | 1 | 1993 | 6662 | 0.000 |
Why?
|
| Leukopenia | 1 | 1977 | 65 | 0.000 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 1977 | 48 | 0.000 |
Why?
|
| Thrombocytopenia | 1 | 1977 | 183 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1977 | 894 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1977 | 1169 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1977 | 1307 | 0.000 |
Why?
|